Bill

Bill > HR5304


US HR5304

PBM Transparency in Prescription Drug Costs Act


summary

Introduced
12/04/2019
In Committee
12/05/2019
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

116th Congress

Bill Summary

A BILL To amend title XXVII of the Public Health Service Act to require health plan oversight of pharmacy benefit manager services, and for other purposes. 1

AI Summary

This bill, the PBM Transparency in Prescription Drug Costs Act, aims to amend the Public Health Service Act to require health plans to oversee pharmacy benefit manager (PBM) services. The key provisions include: 1) prohibiting contracts that limit disclosure of information to plan sponsors, 2) requiring PBMs to submit periodic reports to plan sponsors on drug costs, rebates, and utilization, 3) limiting "spread pricing" where PBMs charge plans more than the amount paid to pharmacies, 4) requiring 100% pass-through of rebates and other remuneration received by PBMs to the health plan, and 5) establishing penalties for non-compliance. The bill also clarifies that these obligations apply to third-party administrators of group health plans.

Committee Categories

Business and Industry, Health and Social Services

Sponsors (2)

Last Action

Referred to the Subcommittee on Health. (on 12/05/2019)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...